Artificial Organs Market by Product Type, Distribution Channel, End User 2024-2032
                     Global Artificial Organs 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  to  the  la tes t  repor t  by  IMARC Group,  t i t l ed  "Art i f ic ia l  Organs 
Market :  Global  Industry  Trends,  Share ,  S ize ,  Growth ,  Opportuni ty  and 
Forecast  2024-2032,"  the  g loba l  a r t i f i c ia l  o rgans market  s ize  reached US$ 
20 .6  B i l l i on  in  2023.
Report Art i f i c ia l  o rgans a re  med ica l  dev ices  tha t  a re  eng ineered  and implan ted in to  
the  human body.  The  o rgans  a re  imp lan ted  in  the  body to  rep l ica te  the  
Highlight and natura l  funct ion  o f  a  hea l thy  o rgan .  Ar t i f i c ia l  o rgans are  made f rom p las t i c  seeded wi th  s tem ce l ls  f rom the  t ransp lant  rec ip ient .  
They inc lude  imp lan tab le  dev ices l i ke  fu l l y  ar t i f i c ia l  hear ts  and pacemakers ,  
Description and o rgan suppor t  mach ines  l ike  d ia lys is  and ex t racorporea l  membrane 
oxygenat ion (ECMO) machines .  They do not  need  con t inuous te ther ing  to  
any power  supp ly  and  s ta t ionary  resources to  func t ion.
Request  for  a  PDF sample  of  th is  report :  
ht tps : / /www. imarcgroup.com/ar t i f i c ia l -o rgans-market / reques tsample
Report Description
Global  Ar t i f i c ia l  Organs  M arket  Trends:
The  marke t  i s  p r imar i l y  d r i ven  by  the  inc reas ing  number  o f  road  acc iden ts  r esu l t i ng  i n  amput a t ions .  The  r i s ing  
inc idences  o f  o rgan  fa i lu res  caused  due t o  b lood  loss ,  d rug  abuse,  se r ious  t r auma,  and  acu t e  d iseases  i s  ano the r  
ma jo r  g rowth - induc ing  fac to r .  A long w i th  t h i s ,  rap id  l i f es t y le  d isorde rs ,  such  as  unhea l thy  d ie t a r y  hab i t s ,  sm ok ing ,  
a lcoho l  consumpt ion ,  and  seden ta ry  l i f es t y l e ,  a re  a l so  esca la t i ng  t he  demand fo r  a r t i f i c ia l  o rgans .  
Bes ides  t h is ,  t he  shor tage o f  o rgan  donors  and  the  i nc reas ing  ge r i a t r i c  popu la t ion  undergo ing  organ  t r ansp lan ts  on  
account  o f  t he i r  de t e r io ra t ing  hea l t h  i s  p rope l l i ng  t he  demand f o r  a r t i f i c ia l  o rgans .  Nowadays ,  t he  r i s i ng  pub l i c  
awareness  abou t  advancemen ts  in  med ica l  t echno logy  and improvemen t s  in  t he  hea l thca re  in f r as t ruc tu re  resu l t i ng  in  
t he  deve lopmen t  o f  a r t i f i c i a l  suppor t  sys t ems .  Fu r t he rmore ,  key  manuf ac t u rer s  a re  in t r oduc ing  3D b iop r i n t ing  and  
in t eg ra t i ng  a r t i f i c i a l  i n te l l i gence  (A I )  i n  a r t i f i c ia l  o rgans ,  t hus  c rea t ing  a  pos i t i ve  ou t look  fo r  t he  marke t .
Look ing  fo rward ,  the  market  va l ue  is  expected  to  reach  US$ 40 . 6  B i l l i on  by  2032,  exh i b i t i ng  a  CAGR o f  7 .6% 
dur ing  the  fo recast  per i od  (2024-2032) .
V i ew Report  TOC,  F igures and  Tab les :  h t tps: / / www. i marcgroup .com/ar t i f i c ia l -o rgans-market
Type Insights:
• Artifi cial  Kidney
• Artifi cial  Heart
• Artifi cial  Pancreas
• Cochlear Implants
• Others
Report 
Segmentation Regional Insights:
• North America
• Europe
• Asia Pacifi c
• Lat in America
• Middle East and Afr ica
• Abiomed, Inc.
• HeartWare International ,  Inc.
• Edwards Lifesciences Corp
Competitive • Boston Scient ifi c Corporation
• Cochlear Limited
Landscape 
with Key 
Players
What was the size of the global artificial organs 
market in 2023?
What is the expected growth rate of the global 
artificial organs market during 2024-2032?
Key What are the key factors driving the global artificial organs market?
Questions What has been the impact of COVID-19 on the 
global artificial organs market?
Answered in 
the Report What is the breakup of the global artificial organs market based on the type?
What are the key regions in the global artificial 
organs market?
Who are the key players/companies in the global 
artificial organs market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5    G l o b a l  A r t i f i c i a l  O r g a n s  M a r k e t    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  B r e a k u p  b y  T y p e
    5 . 5     M a r k e t  B r e a k u p  b y  R e g i o n
    5 . 6     M a r k e t  F o r e c a s t
    5 . 7     S W O T  A n a l y s i s
        5 . 7 . 1     O v e r v i e w
        5 . 7 . 2     S t r e n g t h s
        5 . 7 . 3     W e a k n e s s e s
        5 . 7 . 4     O p p o r t u n i t i e s
        5 . 7 . 5     T h r e a t s
    5 . 8     V a l u e  C h a i n  A n a l y s i s
        5 . 8 . 1     O v e r v i e w
        5 . 8 . 2     R e s e a r c h  a n d  D e v e l o p m e n t
        5 . 8 . 3     R a w  M a t e r i a l  P r o c u r e m e n t
       
        5 . 8 . 4     M a n u f a c t u r i n g
        5 . 8 . 5     M a r k e t i n g
        5 . 8 . 6     D i s t r i b u t i o n
        5 . 8 . 7     E n d - U s e
    5 . 9     P o r t e r s  F i v e  F o r c e s  A n a l y s i s
        5 . 9 . 1     O v e r v i e w
        5 . 9 . 2     B a r g a i n i n g  P o w e r  o f  B u y e r s
        5 . 9 . 3     B a r g a i n i n g  P o w e r  o f  S u p p l i e r s
        5 . 9 . 4     D e g r e e  o f  C o m p e t i t i o n
        5 . 9 . 5     T h r e a t  o f  N e w  E n t r a n t s
        5 . 9 . 6     T h r e a t  o f  S u b s t i t u t e s
Table of 6    M a r k e t  B r e a k u p  b y  T y p e    6 . 1     A r t i f i c i a l  K i d n e y
        6 . 1 . 1     M a r k e t  T r e n d s
        6 . 1 . 2     M a r k e t  F o r e c a s t
Contents     6 . 2     A r t i f i c i a l  H e a r t        6 . 2 . 1     M a r k e t  T r e n d s
        6 . 2 . 2     M a r k e t  F o r e c a s t
    6 . 3     A r t i f i c i a l  P a n c r e a s
        6 . 3 . 1     M a r k e t  T r e n d s
        6 . 3 . 2     M a r k e t  F o r e c a s t
    6 . 4     C o c h l e a r  I m p l a n t s
        6 . 4 . 1     M a r k e t  T r e n d s
        6 . 4 . 2     M a r k e t  F o r e c a s t
    6 . 5     O t h e r s
        6 . 5 . 1     M a r k e t  T r e n d s
        6 . 5 . 2     M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  R e g i o n
    7 . 1     N o r t h  A m e r i c a
        7 . 1 . 1     M a r k e t  T r e n d s
        7 . 1 . 2     M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. i m a rc g ro u p . c o m / a r t i fi c i a l - o rg a n s - m a r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]